Abstract
Valeriana officinalis L. (Caprifoliaceae) has been traditionally used to treat mild nervous tension and sleep problems. The basis of these activities are mainly attributed to valerenic acid through the modulation of the GABA receptor. Moreover, V. officinalis is claimed to have other biological activities such as cardiovascular benefits, anticancer, antimicrobial and spasmolytic. The current review aims to update the biological and pharmacological studies (in vitro, in vivo and clinical trials) of V. officinalis and its major secondary metabolites in order to guide future research. Databases PubMed, Science Direct and Scopus were used for literature search including original papers written in English and published between 2014 and 2020. There have been identified 33 articles which met inclusion criteria. Most of these works were performed with V. officinalis extracts and only a few papers (in vitro and in vivo studies) evaluated the activity of isolated compounds (valerenic acid and volvalerenal acid K). In vitro studies focused on studying antioxidant and neuroprotective activity. In vivo studies and clinical trials mainly investigated activities on the nervous system (anticonvulsant activity, antidepressant, cognitive problems, anxiety and sleep disorders). Just few studies were focused on other different activities, highlight effects on symptoms of premenstrual and postmenopausal syndromes. Valeriana officinalis continues to be one of the medicinal plants most used by today's society for its therapeutic properties and whose biological and pharmacological activities continue to arouse great scientific interest as evidenced in recent publications. This review shows scientific evidence on traditional uses of V. officinalis on nervous system.
Highlights
Valeriana officinalis L. (Caprifoliaceae family), commonly known as “All-heal” (English), “Herbe aux chats” (French) and “Baldrian” (German), is an herbaceous perennial plant that grows extensively in temperate regions in Europe, Asia and North America (Hamaidia et al, 2016; Sundaresan et al, 2018) (Figure 1)
The current review aims to update the biological and pharmacological studies of V. officinalis and its major secondary metabolites to guide future research
There have been identified 33 articles that met the inclusion criteria. Most of these works were performed with V. officinalis extracts, and only a few papers evaluated the activity of isolated compounds
Summary
Valeriana officinalis L. (Caprifoliaceae family), commonly known as “All-heal” (English), “Herbe aux chats” (French) and “Baldrian” (German), is an herbaceous perennial plant that grows extensively in temperate regions in Europe, Asia and North America (Hamaidia et al, 2016; Sundaresan et al, 2018) (Figure 1). Addressing its chemical composition, there have been identified more than 150 different compounds in Valeriana officinalis. The root of V. officinalis has been used since ancient Greece and Rome in traditional medicine until today in modern medicine to improve in the nervous state and to contribute to sleep promotion. The European Medicine Agency (EMA) based on validated scientific data, reported that the well-established use for dry ethanol (4070%) extracts of V. officinalis in solid oral dosage forms is the relief of mild nervous tension and sleep disorders. EMA includes other herbal preparations in V. officinalis monography, which are based on traditional use (more than 30 years of use in therapeutics) for relief of mild symptoms of mental stress and to aid sleep (Anon., 2016). V. officinalis is claimed to have other biological activities such as cardiovascular benefits (reduction in blood pressure and heart rate, antiarrhythmic and regulation of blood lipid levels), anticancer, antimicrobial and spasmolytic (Letchamo et al, 2004; Occhiuto et al, 2009; Chen et al, 2015)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
